Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. - Wikidata - awgldk - TriplyDB

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

http://www.wikidata.org/entity/Q43920387

about

Treatment of psychosis and dementia in Parkinson's disease.Magnetic resonance spectroscopy in the diagnosis of dementia with Lewy bodies.Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions.Lewy body dementia: the impact on patients and caregivers.The spectrum of cognitive impairment in Lewy body diseases Lewy body dementia: the caregiver experience of clinical care.UPDATE ON DEMENTIA WITH LEWY BODIES.Lewy body dementias.Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies.Can we clinically diagnose dementia with Lewy bodies yet?Recognition and management of neuropsychiatric complications in Parkinson's disease.Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis (123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study.Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia.Treatment of dementia with lewy bodies Visual spatial cognition in neurodegenerative disease Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.Outcomes of Inpatient Treatment for Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease Versus Dementia With Lewy Bodies.Comprehensive treatment of dementia with Lewy bodies.Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies.Non-pharmacological interventions for Lewy body dementia: a systematic review.Parkinson's Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

P2860

Q30358337-8EA5D993-0DAA-4EE3-975B-41B3E445EC4F Q30841801-CC083ED3-F893-422D-B63A-CA7BF4371E80 Q33724257-9AA0D553-90BE-4F51-B315-D6CC7F709F10 Q33745870-FFF08B0F-C434-457D-BE3D-C31A23A824FB Q34019751-D00BCBFF-8CBC-4A32-B0DC-CF431BA05353 Q34044014-EE33A2D9-83F3-4A1B-99F4-405EB67DC059 Q34450376-EDD95447-C70F-4471-8F7E-4B1310552F92 Q34502646-DCDD1323-E708-4EED-AADD-5EF173A327EA Q35183572-B7C31A51-78C6-4C37-8782-8A62ED5AC265 Q36315947-6197E733-F2F2-4611-B629-5D6D764F9C68 Q36618103-0E627304-B4D9-475D-B0D4-FBE3AA2F937D Q36673715-E0644B94-8919-4F74-A8AD-0CE7F0330A00 Q36745127-D882977A-A0EF-4D89-B314-D97530BD0A43 Q36810006-B1E8234E-7FCF-4607-B7D5-CF49CF80F2A1 Q37166113-1BE256CF-591C-4E98-B430-0CF9B227C572 Q37552865-37E00B7F-879F-487E-8F15-BA9D4170C4DE Q37763026-957E9416-A1BC-4A38-B48C-471A5ADF331E Q38661735-C5F750F7-3787-4A32-AA37-9435D5501EF3 Q38719322-86630629-EF90-4CD1-AF9B-BB0ADA383896 Q41317541-62AE7116-8F9E-4284-B19E-4B7478D167C3 Q41578551-77452F32-07EA-46E9-AA65-DD4A2489B122 Q42530506-9D4D40C6-200F-4CCB-8756-7C1A002566EB Q43164212-00B4597D-6287-46E5-9BFE-E6BCD459781F Q47587666-2E2559C0-4F10-4A28-99ED-ED94FF41B4FB Q53423472-3B1936BF-5655-4767-B89D-2CC100AFC4B4 Q54982491-EE490660-9EFE-4E18-BAEB-7990B0809091

P2860

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

http://www.wikidata.org/entity/Q43920387

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

@en

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

@nl

type

label

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

@en

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

@nl

prefLabel

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

@en

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

@nl

P1433

Q43920387-58231F8B-870F-4424-B922-247C46692571

P1476

Q43920387-2B49CC06-D281-47DE-8537-054B3D6CC722

P2093

Q43920387-428B5FD0-A51E-4203-81FE-4126A5E165CF

Q43920387-6AE0FD7E-D1B2-400B-B13A-1407D7B462FD

Q43920387-8CCB7AC6-90F6-497E-BA4E-D66690A0558A

Q43920387-A530703D-C98C-40D7-A070-25A84085797B

Q43920387-C5F0A086-8974-4CC9-A677-A337BB2B2FD6

Q43920387-D486372C-060F-4510-843A-25274BE31AD2

P304

Q43920387-2E633AD1-D496-4617-84CA-5274314B433A

P31

Q43920387-45413DC0-0729-4D76-94E5-DFA6DBC46003

P433

Q43920387-487075CE-6C5B-4642-9781-A489FDC6B9D5

P478

Q43920387-AA74091D-0594-4EBD-A046-75F976898E3A

P50

Q43920387-B9D96E0F-BFCD-4FC0-AD1E-3EB8883704A6

Q43920387-EBB59103-AC3A-408D-800D-A12AE57C338C

P577

Q43920387-54BAAF5B-EDB2-4C57-A84C-CA2FB79DEFA7

P698

Q43920387-78CCA68B-E938-4A37-97C8-22AD066DDFD3

P921

Q43920387-9AE631AD-2596-4035-B33D-B61DF2A376ED

P1433

The Journal of Clinical Psychiatry

P1476

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

@en

P2093

Clive G Ballard

http://www.w3.org/2001/XMLSchema#string

David Burn

http://www.w3.org/2001/XMLSchema#string

Elaine K Perry

http://www.w3.org/2001/XMLSchema#string

Ian G McKeith

http://www.w3.org/2001/XMLSchema#string

Jan P Larsen

http://www.w3.org/2001/XMLSchema#string

Robert Perry

http://www.w3.org/2001/XMLSchema#string

P304

633-637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15889951

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease